CLINICAL_TRIALS
trial_result
· 2020-04-21
Clinical Trial Update: A Dose-escalation Study in Subjects With Pulmonary Arterial Hypertension (PAH) [Phase 2]
Summary
Phase 2 dose-escalation trial in pulmonary arterial hypertension (PAH) completed; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: GlaxoSmithKline | Conditions: Hypertension, Pulmonary | Phase 2 | Status: COMPLETED | Results posted: 2020-04-21